Canadian Centre for Preventve Medicine

Bergman S Dr, located in Toronto, ON, is a site where Dr. S. Bergman MD serves as the principal investigator for TACT2, a clinical trial evaluating an alternative treatment for Diabetes and Heart Disease. The trial aims to test the effectiveness of chelation therapy, offering potential insights into innovative healthcare solutions. The website, Longevity.ca, acts as a public platform providing valuable Health and Longevity information, sponsored by Longevity Healthy Aging® (LHA®). Visitors can access a range of resources, including details on the expected growth of centenarians in the next 50 years and facts about longevity from reputable sources like the United Nations Secretariat. By offering a comprehensive outlook on healthy aging and cutting-edge medical research, Bergman S Dr plays a crucial role in advancing knowledge in the field of healthcare. Patients, researchers, and individuals interested in longevity can find a wealth of information to enhance their understanding and contribute to a healthier future. Generated from the website content